Evidence map›Paper›PMID 22101513›Full record

ReviewActa dermato-venereologica2012

Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Andrea L Suárez, Jamison D Feramisco, John Koo, Martin Steinhoff

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Acta dermato-venereologica, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02864498 (A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis), which is not on this map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02864498 phase2completednot on this mapstarted 2017, after this paper: background citation

A Randomised, Double-blind, Placebo-controlled, Phase 2b Study to Assess the Efficacy and Safety of Orally Administered DS107 in Patients With Moderate to Severe Atopic Dermatitis

TypeinterventionalSponsorDS BiopharmaRan2017 to 2018Enrolled321ConditionsAtopic DermatitisArmsDS107, Placebo
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 258 citations in OpenAlex.

  1. Article
  2. Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  3. Psychodermatology: Current Scope and Future Prospects.Indian dermatology online journal · 2026
    Article
  4. ORIGINAL RESEARCH.Discover mental health · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Correlation of non-invasive psycho-physiological and skin-physiological measures.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  17. Article
  18. Atopic Dermatitis: Pathophysiology.Advances in experimental medicine and biology · 2024
    Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Andrea L SuárezDepartment of Dermatology, University of Colorado Denver, School of Medicine, Aurora, USA.
Jamison D Feramisco
John Koo
Martin Steinhoff
University of California, San Francisco · USUniversity of Colorado Denver · US

Funding

Cytokine Signaling in Neurons: Inflammation, Pain and PruritisR01AR059402 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEINHOFF, MARTIN · 2011 to 2013
$1.0M
NIAMS NIH HHS R01 AR059402
6 · The paper itself

Abstract

Atopic dermatitis is a chronic inflammatory skin disease characterized by impaired epidermal barrier function, inflammatory infiltration, extensive pruritus and a clinical course defined by symptomatic flares and remissions. The mechanisms of disease exacerbation are still poorly understood. Clinical occurrence of atopic dermatitis is often associated with psychological stress. In response to stress, upregulation of neuropeptide mediators in the brain, endocrine organs, and peripheral nervous system directly affect immune and resident cells in the skin. Lesional and non-lesional skin of patients with atopic dermatitis demonstrates increased mast cells and mast cell-nerve fiber contacts. In the setting of stress, sensory nerves release neuromediators that regulate inflammatory and immune responses, as well as barrier function. Progress towards elucidating these neuroimmune connections will refine our understanding of how emotional stress influences atopic dermatitis. Moreover, psychopharmacologic agents that modulate neuronal receptors or the amplification circuits of inflammation are attractive options for the treatment of not only atopic dermatitis, but also other stress-mediated inflammatory skin diseases.

Indexed as

NeuroimmunomodulationCytokinesDermatitis, AtopicHumansHypothalamo-Hypophyseal SystemMast CellsPituitary-Adrenal SystemReceptors, NeurotransmitterStress, PsychologicalT-LymphocytesCytokinesReceptors, Neurotransmitter

Identifiers

PMID22101513
PMCPMC3704139
OpenAlexW2154283431

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.